XML 28 R50.htm IDEA: XBRL DOCUMENT v2.4.1.9
Convertible Preferred Stock, Common Stock and Stockholders' Deficit - Additional Information (Detail) (USD $)
0 Months Ended 1 Months Ended 12 Months Ended 27 Months Ended
Sep. 07, 2012
Nov. 30, 2014
Jul. 31, 2013
Oct. 31, 2012
Dec. 31, 2014
Vote
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Class of Stock [Line Items]                
Reverse stock split of common stock 0.5us-gaap_StockholdersEquityNoteStockSplitConversionRatio1              
Preferred stock, shares authorized             10,000,000us-gaap_PreferredStockSharesAuthorized  
Convertible preferred stock, shares outstanding         0us-gaap_TemporaryEquitySharesOutstanding      
Common stock shares, issued   6,088,235us-gaap_StockIssuedDuringPeriodSharesNewIssues 5,175,000us-gaap_StockIssuedDuringPeriodSharesNewIssues          
Price per share   $ 17.00us-gaap_EquityIssuancePerShareAmount $ 9.50us-gaap_EquityIssuancePerShareAmount          
Proceeds from issuance of common stock     $ 45,800,000us-gaap_ProceedsFromIssuanceOfCommonStock $ 70,000,000us-gaap_ProceedsFromIssuanceOfCommonStock $ 86,146,000us-gaap_ProceedsFromIssuanceOfCommonStock $ 45,980,000us-gaap_ProceedsFromIssuanceOfCommonStock $ 65,788,000us-gaap_ProceedsFromIssuanceOfCommonStock  
Proceeds from public offering   76,300,000us-gaap_ProceedsFromIssuanceInitialPublicOffering            
Common stock, shares outstanding         48,944,530us-gaap_CommonStockSharesOutstanding 41,787,326us-gaap_CommonStockSharesOutstanding   41,787,326us-gaap_CommonStockSharesOutstanding
Number of votes of each share of common stock         1rgls_CommonStockVotesPerShare      
Weighted average grant date fair value         $ 8.37us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue $ 4.14us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue $ 2.97us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue  
The total intrinsic value of stock options exercised         12,100,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue 5,700,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue 800,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue  
Cash received from exercise of common stock options         2,200,000us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions 600,000us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions 100,000us-gaap_EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions  
Compensation cost related to non-vested awards not yet recognized         17,400,000us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized      
Weighted-average recognition period of compensation cost related to non-vested awards not yet recognized         1 year 10 months 24 days      
2012 Purchase Plan                
Class of Stock [Line Items]                
Percentage of participants eligible compensation       15.00%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
/ us-gaap_AwardTypeAxis
= rgls_EmployeeStockPurchasePlanTwentyTwelveMember
       
Common stock shares issued under purchase plan         38,085us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
/ us-gaap_AwardTypeAxis
= rgls_EmployeeStockPurchasePlanTwentyTwelveMember
    86,120us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
/ us-gaap_AwardTypeAxis
= rgls_EmployeeStockPurchasePlanTwentyTwelveMember
Common stock shares reserved for future issuance and authorized for purchase         840,071us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
/ us-gaap_AwardTypeAxis
= rgls_EmployeeStockPurchasePlanTwentyTwelveMember
     
2012 Purchase Plan | At inception of the enrollment period                
Class of Stock [Line Items]                
Percentage of fair market value of common stock       85.00%us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
/ us-gaap_AwardTypeAxis
= rgls_EmployeeStockPurchasePlanTwentyTwelveMember
/ us-gaap_StatementScenarioAxis
= rgls_ScenarioOneMember
       
2012 Purchase Plan | At applicable purchase date                
Class of Stock [Line Items]                
Percentage of fair market value of common stock       85.00%us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
/ us-gaap_AwardTypeAxis
= rgls_EmployeeStockPurchasePlanTwentyTwelveMember
/ us-gaap_StatementScenarioAxis
= rgls_ScenarioTwoMember
       
Minimum                
Class of Stock [Line Items]                
Estimated forfeiture rate         5.00%rgls_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
5.00%rgls_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
   
Maximum                
Class of Stock [Line Items]                
Estimated forfeiture rate         8.00%rgls_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
8.00%rgls_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
   
Parent Company                
Class of Stock [Line Items]                
Common stock shares, issued   4,808,824us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ dei_LegalEntityAxis
= us-gaap_ParentCompanyMember
           
Isis Pharmaceuticals Inc                
Class of Stock [Line Items]                
Common stock shares, issued   1,279,411us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_RelatedPartyTransactionAxis
= rgls_IsisPharmaceuticalsIncMember
           
Initial Public Offering                
Class of Stock [Line Items]                
Common stock shares, issued       11,250,000us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_SubsidiarySaleOfStockAxis
= us-gaap_IPOMember
       
Price per share       $ 4.00us-gaap_EquityIssuancePerShareAmount
/ us-gaap_SubsidiarySaleOfStockAxis
= us-gaap_IPOMember
       
Proceeds from issuance of common stock       39,500,000us-gaap_ProceedsFromIssuanceOfCommonStock
/ us-gaap_SubsidiarySaleOfStockAxis
= us-gaap_IPOMember
       
Initial Public Offering | Convertible Note Payable                
Class of Stock [Line Items]                
Common stock issued upon conversion of convertible notes       2,703,269us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
/ us-gaap_ShareholdersEquityClassAxis
= us-gaap_ConvertibleNotesPayableMember
/ us-gaap_SubsidiarySaleOfStockAxis
= us-gaap_IPOMember
       
Initial Public Offering | Convertible Preferred Stock                
Class of Stock [Line Items]                
Common stock issued upon conversion of convertible notes       13,699,999us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
/ us-gaap_ShareholdersEquityClassAxis
= us-gaap_ConvertiblePreferredStockMember
/ us-gaap_SubsidiarySaleOfStockAxis
= us-gaap_IPOMember
       
Astra Zeneca                
Class of Stock [Line Items]                
Common stock shares, issued       6,250,000us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_SubsidiarySaleOfStockAxis
= rgls_AstraZenecaMember
       
Price per share       $ 4.00us-gaap_EquityIssuancePerShareAmount
/ us-gaap_SubsidiarySaleOfStockAxis
= rgls_AstraZenecaMember
       
Proceeds from issuance of common stock       25,000,000us-gaap_ProceedsFromIssuanceOfCommonStock
/ us-gaap_SubsidiarySaleOfStockAxis
= rgls_AstraZenecaMember
       
Underwriter                
Class of Stock [Line Items]                
Common stock shares, issued       1,480,982us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_SubsidiarySaleOfStockAxis
= rgls_UnderwriterMember
       
Price per share       $ 4.00us-gaap_EquityIssuancePerShareAmount
/ us-gaap_SubsidiarySaleOfStockAxis
= rgls_UnderwriterMember
       
Proceeds from issuance of common stock       $ 5,500,000us-gaap_ProceedsFromIssuanceOfCommonStock
/ us-gaap_SubsidiarySaleOfStockAxis
= rgls_UnderwriterMember